Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia GlobeNewswire May 06, 2024 Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found...
ArisGlobal, a market leader in Life Sciences technology and the creator of LifeSphere®, announced today that research-driven global pharmaceutical company Boehringer Ingelheim is adopting the transformative new functionality of LifeSphere® Clarity™. LifeSphere Clarity picks up where traditional signal detection ...
The UAE Ministry of Health and Prevention (MOHAP) has approved the first and only therapy by Boehringer Ingelheim for the treatment of adult generalised pustular psoriasis flares.
The UAE Ministry of Health and Prevention (MOHAP) has
The collaboration with the Atlanta Braves Foundation and Ozzie Albies Foundation supports the Dog Days of Summer Adoption Program during the 2024 MLB season and a special game sponsorship on